Progestogen-only Injectables

FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended June 2020)

24 June 2020

This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.

This document is up-to-date

FSRH CEU Statement: Self-Administration of Sayana Press® (September 2015)

01 September 2015

The CEU supports the self administration of Sayana Press® because of its potential benefits to women and services. It offers women greater choice and more autonomy over their contraception and fertility.

This document is up-to-date

Privacy notice

FSRH Clinical Guideline: Progestogen-only Injectable (December 2014, Amended June 2020)

FSRH CEU Statement: Self-Administration of Sayana Press® (September 2015)